
Director, President, CEO and Director · ACTUATE THERAPEUTICS, INC. · Common Stock
Tax withholding — administrative, little informational value
$122K reported value · 66.5% of prior position
Disclosed 0 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 65.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 36.1K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 269.3K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 82.5K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 133.1K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 82.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 195.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 269.3K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 87.7K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 368.3K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 368.3K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 36.1K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 126.2K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 65.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 82.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 195.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 824.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund I, LPDirector, 10% Owner | Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 | |
| 9 | BIOS Fund III, LPDirector, 10% Owner | Grant or award | A | — 87.7K sh | Oct 30, 2026 traded Oct 28, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $121,726
Schmitt Daniel M filed this Form 4 reporting a tax withholding of ACTU on Aug 14, 2026. It became public on Aug 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.